Reports
Sale
Global Aortic Valve Replacement Devices Market Size, Share, Forecast: By Surgery Type: Open Surgery, Minimally Invasive Surgery; By Product Type: Transcatheter Aortic Valve, Sutureless Aortic Valve Replacement (SUAVR); By End User: Hospitals, Ambulatory Surgical Centres, Others; Regional Analysis; Supplier Landscape; 2023-2031
Global Aortic Valve Replacement Devices Market Outlook
The global aortic valve replacement devices market size reached a value of USD 8,308.8 million in 2022. The market is estimated to witness a CAGR of 6.8% during the forecast period of 2023-2031 to reach a value of USD 15,020.33 million by 2031.
Global Aortic Valve Replacement Devices Market: Introduction and Analysis
Aortic valve replacement is a procedure in which the failing aortic valve of a patient's heart is replaced with an artificial heart valve. Aortic valve replacement devices are used to perform this procedure. The artificial or prosthetic valve used could be built of synthetic materials or animal tissues.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America has been the main revenue contributor in the historical era because of the growing prevalence of valvular problems, the growing elderly population, and the growing knowledge of the benefits of TAVR over alternative medical treatment. However, due to the improving healthcare infrastructure in emerging economies like China and India, the Asia Pacific is anticipated to witness a significant growth in the forecast period. Moreover, owing to the presence of a large population and the rising frequency of heart disease, these countries have a growing market. Furthermore, expanding healthcare infrastructure and services, rising disposable income, and increased government funding are some of the factors that are expected to drive the market expansion in the Asia Pacific region throughout the forecast period.
Hospitals account for a major portion of the aortic valve replacement devices industry based on end use. The key factor supporting the segment's dominance is the enormous number of patients admitted to hospitals. Because many growing countries rely on hospitals for primary healthcare, this segment is likely to increase rapidly during the forecast period. Furthermore, the aortic valve replacement devices industry is expected to expand in the next few years as hospitals increase their efforts to provide the public with the most up-to-date procedures and services.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Aortic Valve Replacement Devices: Market Segmentation
Market Breakup by Surgery Type
- Open Surgery
- Minimally Invasive Surgery
Market Breakup by Product Type
- Transcatheter Aortic Valve
- Sutureless Aortic Valve Replacement (SUAVR)
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
\
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Aortic Valve Replacement Devices Market Overview
The market is growing because of the rising prevalence of valvular illnesses, including aortic stenosis and aortic regurgitation. The various government initiatives aimed at raising awareness regarding valve replacement surgeries are also projected to contribute to the market growth. The growing geriatric population is having a significant impact on the market growth. In addition, the favourable reimbursement scenario and replacement surgery developments are projected to favour the industry growth in the forecast period. The prevalence of numerous ailments, as well as people's healthcare expenses, is increasing. As a result, the public cannot cover the majority of the health care expenses from their own pockets. As a result, the introduction of government programmes to aid the public by covering a portion of their healthcare costs is likely to contribute considerably to the market growth throughout the forecast period.
Key Players in the Global Aortic Valve Replacement Devices Market
The report presents a detailed analysis of the following key players in the global aortic valve replacement devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Boston Scientific Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Medtronic
- CryoLife, Inc.
- Abbott
- JenaValve Technology, Inc.
- Micro Interventional Devices
- Braile Biomedica
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Surgery Type |
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Aortic Valve Replacement Devices Market Overview
3.1 Global Aortic Valve Replacement Devices Market Historical Value (2016-2022)
3.2 Global Aortic Valve Replacement Devices Market Forecast Value (2023-2031)
4 Global Aortic Valve Replacement Devices Market Landscape
4.1 Global Aortic Valve Replacement Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Aortic Valve Replacement Devices Product Landscape
4.2.1 Analysis by Surgery Type
4.2.2 Analysis by Product Type
5 Global Aortic Valve Replacement Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Aortic Valve Replacement Devices Market Segmentation
6.1 Global Aortic Valve Replacement Devices Market by Surgery Type
6.1.1 Market Overview
6.1.2 Open Surgery
6.1.3 Minimally Invasive Surgery
6.2 Global Aortic Valve Replacement Devices Market by Product Type
6.2.1 Market Overview
6.2.2 Transcatheter Aortic Valve
6.2.3 Sutureless Aortic Valve Replacement (SUAVR)
6.3 Global Aortic Valve Replacement Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centres
6.3.4 Others
6.4 Global Aortic Valve Replacement Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Aortic Valve Replacement Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Aortic Valve Replacement Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Aortic Valve Replacement Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Aortic Valve Replacement Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Aortic Valve Replacement Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 LivaNova PLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Edwards Lifesciences Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 CryoLife, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abbott
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 JenaValve Technology, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Micro Interventional Devices
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Braile Biomedica
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
18 Global Aortic Valve Replacement Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global aortic valve replacement devices market size reached a value of USD 8,308.8 million in 2022.
The market is estimated to witness a CAGR of 6.8% during the forecast period of 2023-2031 to reach a value of USD 15,020.33 million by 2031.
The growth of the market is driven by factors like the rising healthcare infrastructure and services, rising disposable income, and increased government funding.
The key trends guiding the growth of the market include the government initiatives aimed at raising awareness regarding valve replacement surgeries.
The major regional markets for the product include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The surgery types can be divided into open surgery and minimally invasive surgery.
The product types include transcatheter aortic valve and sutureless aortic valve replacement (SUAVR).
The end-users in the market can be categorised into hospitals and ambulatory surgical centres, among others.
The key players can be categorised into Boston Scientific Corporation, LivaNova PLC, Edwards Lifesciences Corporation, Medtronic, CryoLife, Inc., Abbott, JenaValve Technology, Inc., Micro Interventional Devices, and Braile Biomedica.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999$5999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER